GB1593609A - Pyridine sulfonamides - Google Patents
Pyridine sulfonamides Download PDFInfo
- Publication number
- GB1593609A GB1593609A GB3918/78A GB391878A GB1593609A GB 1593609 A GB1593609 A GB 1593609A GB 3918/78 A GB3918/78 A GB 3918/78A GB 391878 A GB391878 A GB 391878A GB 1593609 A GB1593609 A GB 1593609A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- group
- compounds
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- DWJMBQYORXLGAE-UHFFFAOYSA-N pyridine-2-sulfonamide Chemical class NS(=O)(=O)C1=CC=CC=N1 DWJMBQYORXLGAE-UHFFFAOYSA-N 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 66
- 238000000034 method Methods 0.000 claims description 48
- 238000002360 preparation method Methods 0.000 claims description 29
- 229910052739 hydrogen Inorganic materials 0.000 claims description 25
- 239000001257 hydrogen Substances 0.000 claims description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 23
- -1 tetrahydrofurfuryl group Chemical group 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 239000012948 isocyanate Substances 0.000 claims description 7
- 150000002513 isocyanates Chemical class 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 159000000000 sodium salts Chemical class 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 claims description 2
- JEOCBTLWXWAGJM-UHFFFAOYSA-N n-chlorosulfamoyl chloride Chemical compound ClNS(Cl)(=O)=O JEOCBTLWXWAGJM-UHFFFAOYSA-N 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- FMLHTZVGNSACKP-UHFFFAOYSA-N pyridin-2-ylsulfonylurea Chemical compound NC(=O)NS(=O)(=O)C1=CC=CC=N1 FMLHTZVGNSACKP-UHFFFAOYSA-N 0.000 claims description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 238000002844 melting Methods 0.000 description 22
- 230000008018 melting Effects 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 229910002651 NO3 Inorganic materials 0.000 description 15
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 150000003927 aminopyridines Chemical class 0.000 description 6
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000002808 molecular sieve Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 5
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- CLKVRMZVSPIGOL-UHFFFAOYSA-N 2-amino-4-(3-methylphenyl)pyridine-3-sulfonamide Chemical compound CC1=CC=CC(C=2C(=C(N)N=CC=2)S(N)(=O)=O)=C1 CLKVRMZVSPIGOL-UHFFFAOYSA-N 0.000 description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 2
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 2
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical compound NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical compound NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- RGXUCUWVGKLACF-UHFFFAOYSA-N (3-methylphenyl)methanamine Chemical compound CC1=CC=CC(CN)=C1 RGXUCUWVGKLACF-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical class 0.000 description 1
- QAFSRNATTVQZKY-UHFFFAOYSA-N 1-[[4-[(3-methylphenyl)methylamino]pyridin-3-yl]sulfamoyl]-n-propan-2-ylformamide Chemical compound CC(C)NC(=O)S(=O)(=O)NC1=CN=CC=C1NCC1=CC=CC(C)=C1 QAFSRNATTVQZKY-UHFFFAOYSA-N 0.000 description 1
- ZXPCUGWAKUIOOF-UHFFFAOYSA-N 4-(3-methylanilino)pyridine-3-sulfonamide Chemical compound CC1=CC=CC(NC=2C(=CN=CC=2)S(N)(=O)=O)=C1 ZXPCUGWAKUIOOF-UHFFFAOYSA-N 0.000 description 1
- 101800001195 Crustacean hyperglycemic hormone 3 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101000913968 Ipomoea purpurea Chalcone synthase C Proteins 0.000 description 1
- QCOGKXLOEWLIDC-UHFFFAOYSA-N N-methylbutylamine Chemical compound CCCCNC QCOGKXLOEWLIDC-UHFFFAOYSA-N 0.000 description 1
- 101000986989 Naja kaouthia Acidic phospholipase A2 CM-II Proteins 0.000 description 1
- 101000907988 Petunia hybrida Chalcone-flavanone isomerase C Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- LUTSRLYCMSCGCS-BWOMAWGNSA-N [(3s,8r,9s,10r,13s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,16-decahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC=C3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 LUTSRLYCMSCGCS-BWOMAWGNSA-N 0.000 description 1
- QCAIWXWGXAKQDU-UHFFFAOYSA-N [4-(3-methylanilino)pyridin-2-yl]sulfamoylformamide Chemical compound C(N)(=O)S(=O)(=O)NC1=NC=CC(=C1)NC1=CC(=CC=C1)C QCAIWXWGXAKQDU-UHFFFAOYSA-N 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002425 furfuryl group Chemical class C(C1=CC=CO1)* 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- LYBKPDDZTNUNNM-UHFFFAOYSA-N isopropylbenzylamine Chemical compound CC(C)NCC1=CC=CC=C1 LYBKPDDZTNUNNM-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- SCBOHEAYJPFSBZ-UHFFFAOYSA-N n-(diethylamino)carbamoyl chloride Chemical compound CCN(CC)NC(Cl)=O SCBOHEAYJPFSBZ-UHFFFAOYSA-N 0.000 description 1
- AHCUKJAPVYFFDI-UHFFFAOYSA-N nitric acid;1-[[4-(pentylamino)pyridin-3-yl]sulfamoyl]-n-propan-2-ylformamide Chemical compound O[N+]([O-])=O.CCCCCNC1=CC=NC=C1NS(=O)(=O)C(=O)NC(C)C AHCUKJAPVYFFDI-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- FVVQIOWEGMNIKB-UHFFFAOYSA-N pyridin-2-ylsulfonylcarbamic acid Chemical compound OC(=O)NS(=O)(=O)C1=CC=CC=N1 FVVQIOWEGMNIKB-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3918/78A GB1593609A (en) | 1978-01-31 | 1978-01-31 | Pyridine sulfonamides |
| MX10115779U MX6977E (es) | 1978-01-31 | 1979-01-05 | Procedimiento para preparar derivados de sulfonamidopiridina |
| ZA7990A ZA7990B (en) | 1978-01-31 | 1979-01-09 | New derivatives of pyridine,the preparation and use thereof |
| ES476658A ES476658A1 (es) | 1978-01-31 | 1979-01-09 | Procedimiento para preparar derivados de sulfonamido-piridi-na |
| IL56407A IL56407A (en) | 1978-01-31 | 1979-01-10 | 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them |
| AU43317/79A AU524287B2 (en) | 1978-01-31 | 1979-01-12 | Derivatives of pyridine |
| NZ189376A NZ189376A (en) | 1978-01-31 | 1979-01-15 | Pyridine derivatives and pharmaceutical compositions |
| CA319,934A CA1124720A (en) | 1978-01-31 | 1979-01-19 | Derivatives of 4-amino-3-sulfonamido-pyridine |
| EP79200037A EP0003383B1 (fr) | 1978-01-31 | 1979-01-22 | Dérivés de 4-amino-3-sulfonamido-pyridine |
| DE7979200037T DE2964681D1 (de) | 1978-01-31 | 1979-01-22 | 4-amino-3-sulfonamido pyridine derivatives |
| BE0/193040A BE873656A (fr) | 1978-01-31 | 1979-01-23 | Nouveaux derives de la pyridine, leur preparation et leur utilisation |
| US06/006,154 US4244950A (en) | 1978-01-31 | 1979-01-24 | Derivatives of 4-amino-3-sulfonamido-pyridine, their preparation and use |
| AR275290A AR226154A1 (es) | 1978-01-31 | 1979-01-25 | Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables |
| IT19614/79A IT1109868B (it) | 1978-01-31 | 1979-01-25 | Derivati della piridina,loro preparazione e loro impiego |
| FR7902109A FR2416225A1 (fr) | 1978-01-31 | 1979-01-26 | Derives de la 4-amino-3 sulfamido-pyridine, leur procede de preparation et leur application comme diuretiques |
| AT0059479A AT375646B (de) | 1978-01-31 | 1979-01-26 | Verfahren zur herstellung von neuen sulfonamidopyridinderivaten und deren salzen |
| PT7969147A PT69147A (en) | 1978-01-31 | 1979-01-29 | New derivatives of pyridine the preparation and use thereof |
| DD79210692A DD141309A5 (de) | 1978-01-31 | 1979-01-29 | Verfahren zur herstellung von sulfonamid-pyridin-derivaten |
| LU80856A LU80856A1 (fr) | 1978-01-31 | 1979-01-30 | Nouveaux derives de la pyridine, leur preparation et leur utilisation |
| HU79CI1905A HU178203B (en) | 1978-01-31 | 1979-01-30 | Process for producing sulfonamido-pyridine derivatives |
| JP1026079A JPS54119477A (en) | 1978-01-31 | 1979-01-30 | Pyridine derivative and its manufacture and use |
| AR281219A AR225922A1 (es) | 1978-01-31 | 1980-05-28 | Procedimiento para preparar nuevos derivados de 3-carbamoil-sulfonamido-4-amino-piridina y sus sales |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3918/78A GB1593609A (en) | 1978-01-31 | 1978-01-31 | Pyridine sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1593609A true GB1593609A (en) | 1981-07-22 |
Family
ID=9767352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3918/78A Expired GB1593609A (en) | 1978-01-31 | 1978-01-31 | Pyridine sulfonamides |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4244950A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0003383B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS54119477A (cg-RX-API-DMAC7.html) |
| AR (2) | AR226154A1 (cg-RX-API-DMAC7.html) |
| AT (1) | AT375646B (cg-RX-API-DMAC7.html) |
| AU (1) | AU524287B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE873656A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1124720A (cg-RX-API-DMAC7.html) |
| DD (1) | DD141309A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2964681D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES476658A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2416225A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1593609A (cg-RX-API-DMAC7.html) |
| HU (1) | HU178203B (cg-RX-API-DMAC7.html) |
| IL (1) | IL56407A (cg-RX-API-DMAC7.html) |
| IT (1) | IT1109868B (cg-RX-API-DMAC7.html) |
| LU (1) | LU80856A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ189376A (cg-RX-API-DMAC7.html) |
| PT (1) | PT69147A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA7990B (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114456104A (zh) * | 2022-01-26 | 2022-05-10 | 南京正科医药股份有限公司 | 一种托拉塞米关键中间体的合成方法 |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4544401A (en) * | 1979-10-22 | 1985-10-01 | E. I. Du Pont De Nemours And Company | Agricultural pyridinesulfonamides |
| US4435206A (en) | 1978-12-04 | 1984-03-06 | E. I. Du Pont De Nemours And Company | Agricultural pyridinesulfonamides |
| US4879249A (en) * | 1983-02-25 | 1989-11-07 | Baldwin Thomas O | Linker compounds, linker-compound-ligands and linker-compound-receptors |
| US4734275A (en) * | 1983-08-19 | 1988-03-29 | Research Corporation | Anti-curare agents |
| DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| US4914203A (en) * | 1987-07-24 | 1990-04-03 | American Home Products Corporation | 5 step process for preparing certain 2,4-diamino-5-pyrimidine-sulfonyl ureas |
| US4853389A (en) * | 1987-07-24 | 1989-08-01 | American Home Products Corporation | Diuretic and antihypertensive substituted-5-pyrimidinesulfonylureas |
| US5166162A (en) * | 1990-03-02 | 1992-11-24 | Adir Et Compagnie | Pyridylsulfonylurea and pyridylsulfonylthiourea compounds |
| FR2659080B1 (fr) * | 1990-03-02 | 1994-07-08 | Adir | Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2685917A1 (fr) * | 1992-01-06 | 1993-07-09 | Adir | Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant. |
| EP1741429A3 (en) * | 2000-03-20 | 2007-01-17 | Teva Pharmaceutical Industries Ltd. | Processes for preparing torsemide |
| NZ521852A (en) | 2000-03-20 | 2004-10-29 | Teva Pharma | Novel processes for preparing torsemide intermediate |
| DE10027887A1 (de) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| AR037097A1 (es) * | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
| AR039156A1 (es) * | 2002-03-28 | 2005-02-09 | Novartis Ag | Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide |
| IL149771A0 (en) * | 2002-05-21 | 2002-11-10 | Fintech Lab Ltd | Process for preparation of torsemide |
| US7378527B2 (en) * | 2004-03-16 | 2008-05-27 | Daqing Che | Process for the preparation of torsemide and related intermediates |
| US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
| DE102005057421A1 (de) * | 2005-11-30 | 2007-05-31 | Bayer Schering Pharma Ag | Heteroaromatische Sulfonamid-Prodrugs |
| AR061159A1 (es) | 2007-06-01 | 2008-08-06 | S A Cartocor | Procedimiento de fabricacion de un pallet modular y producto resultante |
| EP3649112A1 (en) | 2017-07-07 | 2020-05-13 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| US20260078092A1 (en) * | 2024-09-19 | 2026-03-19 | Salim Shah | Sulfonyl carboxamide compound, their derivatives, and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758749A (fr) * | 1969-11-12 | 1971-05-10 | Ciba Geigy | Procede de preparation de nouveaux acides pyridine-sulfoniques |
| GB1368948A (en) * | 1970-11-11 | 1974-10-02 | Manuf Prod Pharma | Pyridine derivatives |
| GB1414793A (en) * | 1972-07-28 | 1975-11-19 | Manuf Prod Pharma | Derivatives of phenylaminopyridine |
| US3956294A (en) * | 1972-06-22 | 1976-05-11 | Cassella Farbwerke Mainkur Aktiengesellschaft | Substituted pyridine compounds |
| GB1477664A (en) * | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
-
1978
- 1978-01-31 GB GB3918/78A patent/GB1593609A/en not_active Expired
-
1979
- 1979-01-09 ES ES476658A patent/ES476658A1/es not_active Expired
- 1979-01-09 ZA ZA7990A patent/ZA7990B/xx unknown
- 1979-01-10 IL IL56407A patent/IL56407A/xx unknown
- 1979-01-12 AU AU43317/79A patent/AU524287B2/en not_active Ceased
- 1979-01-15 NZ NZ189376A patent/NZ189376A/xx unknown
- 1979-01-19 CA CA319,934A patent/CA1124720A/en not_active Expired
- 1979-01-22 EP EP79200037A patent/EP0003383B1/fr not_active Expired
- 1979-01-22 DE DE7979200037T patent/DE2964681D1/de not_active Expired
- 1979-01-23 BE BE0/193040A patent/BE873656A/xx unknown
- 1979-01-24 US US06/006,154 patent/US4244950A/en not_active Expired - Lifetime
- 1979-01-25 IT IT19614/79A patent/IT1109868B/it active
- 1979-01-25 AR AR275290A patent/AR226154A1/es active
- 1979-01-26 AT AT0059479A patent/AT375646B/de not_active IP Right Cessation
- 1979-01-26 FR FR7902109A patent/FR2416225A1/fr active Granted
- 1979-01-29 PT PT7969147A patent/PT69147A/pt unknown
- 1979-01-29 DD DD79210692A patent/DD141309A5/de not_active IP Right Cessation
- 1979-01-30 JP JP1026079A patent/JPS54119477A/ja active Pending
- 1979-01-30 LU LU80856A patent/LU80856A1/fr unknown
- 1979-01-30 HU HU79CI1905A patent/HU178203B/hu not_active IP Right Cessation
-
1980
- 1980-05-28 AR AR281219A patent/AR225922A1/es active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114456104A (zh) * | 2022-01-26 | 2022-05-10 | 南京正科医药股份有限公司 | 一种托拉塞米关键中间体的合成方法 |
| CN114456104B (zh) * | 2022-01-26 | 2023-08-25 | 南京正科医药股份有限公司 | 一种托拉塞米关键中间体的合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| LU80856A1 (fr) | 1980-08-08 |
| AR225922A1 (es) | 1982-05-14 |
| AU4331779A (en) | 1979-08-09 |
| IT7919614A0 (it) | 1979-01-25 |
| ATA59479A (de) | 1984-01-15 |
| FR2416225A1 (fr) | 1979-08-31 |
| AR226154A1 (es) | 1982-06-15 |
| DE2964681D1 (de) | 1983-03-17 |
| NZ189376A (en) | 1981-03-16 |
| EP0003383B1 (fr) | 1983-02-09 |
| CA1124720A (en) | 1982-06-01 |
| ZA7990B (en) | 1980-10-29 |
| IL56407A (en) | 1983-05-15 |
| DD141309A5 (de) | 1980-04-23 |
| IT1109868B (it) | 1985-12-23 |
| HU178203B (en) | 1982-03-28 |
| IL56407A0 (en) | 1979-03-12 |
| EP0003383A2 (fr) | 1979-08-08 |
| EP0003383A3 (en) | 1979-09-05 |
| JPS54119477A (en) | 1979-09-17 |
| AT375646B (de) | 1984-08-27 |
| AU524287B2 (en) | 1982-09-09 |
| PT69147A (en) | 1979-02-01 |
| FR2416225B1 (cg-RX-API-DMAC7.html) | 1981-11-06 |
| BE873656A (fr) | 1979-07-23 |
| ES476658A1 (es) | 1979-07-16 |
| US4244950A (en) | 1981-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1124720A (en) | Derivatives of 4-amino-3-sulfonamido-pyridine | |
| USRE30633E (en) | 3-Lower alkylcarbamylsulfonamido-4-phenylaminopyridines, n-oxides, derivatives thereof and pharmaceutical compositions containing same | |
| US3635982A (en) | Amino-substituted-quinoxalinyloxazolidines and -oxazines | |
| US3995039A (en) | Pyrazolo [1,5-a] [1,3,5] triazines | |
| JPS6344753B2 (cg-RX-API-DMAC7.html) | ||
| SU999972A3 (ru) | Способ получени производных пиридо-(1,2-а) пиримидина или их фармацевтически приемлемых солей,или их оптически активных изомеров | |
| US4207327A (en) | N-(4-Pyrazolidinyl)benzamides and their amino precursors | |
| US4052508A (en) | Heterocyclic dihydroanthracen imines | |
| CA1082699A (en) | Fused pyrimidine derivatives and process for the preparation thereof | |
| US3821226A (en) | 6-methyl-8b-ureido-ergolenes | |
| EP0053789A1 (en) | 2-Pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent | |
| US3963735A (en) | Acylated 2-aminothiazole derivatives | |
| Antonini et al. | Indolizine derivatives with biological activity IV: 3‐(2‐Aminoethyl)‐2‐methylindolizine, 3‐(2‐aminoethyl)‐2‐methyl‐5, 6, 7, 8‐tetrahydroindolizine, and their iv‐alkyl derivatives | |
| US4060638A (en) | Anthranilic acid amides | |
| US4287211A (en) | Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions | |
| US4207317A (en) | 1-Aryl-4-carbamoyl-pyrazolin-5-ones | |
| GB1597091A (en) | Pyrazolopyridines | |
| US3709917A (en) | N-acyl and n-organosulfonyl mono-or di-substituted sulfamoylbenzenesulfonamides | |
| CA1040640A (en) | Indazole-3-carboxylic acid hydrazides and a process for the preparation thereof | |
| USRE28939E (en) | 3-Aminoindazole derivatives | |
| US4166126A (en) | 1-benzothiepin-4-carboxamides | |
| US4131679A (en) | Substituted 4-hydroxy pyridones | |
| US3959261A (en) | Biphenyl compounds | |
| US3790572A (en) | 2-hydroxyalkyl-4,5-dihydropyridazin-3(2h)-one derivatives | |
| US4495189A (en) | Condensed pyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |